Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
Dow
Argus Health
Queensland Health
US Army
Farmers Insurance
Boehringer Ingelheim
Citi

Generated: April 26, 2018

DrugPatentWatch Database Preview

NITROPRESS Drug Profile

« Back to Dashboard

When do Nitropress patents expire, and what generic alternatives are available?

Nitropress is a drug marketed by Abbott, Abbvie, and Hospira. and is included in four NDAs.

The generic ingredient in NITROPRESS is sodium nitroprusside. There are one thousand four hundred and twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
Drug patent expirations by year for NITROPRESS
Pharmacology for NITROPRESS
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for NITROPRESS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 071555-001 Nov 16, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 070566-001 Jun 9, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 018450-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 071961-001 Aug 1, 1988 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
Colorcon
US Department of Justice
Covington
Mallinckrodt
McKesson
Moodys
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.